Dingco Biotechnology is set to transform the field of diagnostics with its advanced, fully automated Thin Layer Cytology Preparation Machines and Intelligent Dyeing and Sealing Integrated Machines. In a groundbreaking presentation at the just ended 5th edition of the AI Diagnosis Seminar Series focused on “AI in Medical Imaging & Smart Diagnostics, Dingco Biotechnology introduced its flagship technologies designed to enhance diagnostic accuracy, reduce human error, and streamline workflow efficiency in pathology labs.
Founded in 2021, Dingco Biotechnology has quickly established itself as a pioneer in automated pathological detection equipment in China. With production bases in Ningbo and Wuhan, the company boasts nearly 100 intellectual property rights and 40 medical device registrations, reinforcing its commitment to innovation in pathology automation.
Dingco’s flagship products, the DKYJ40 & DKYJ120 Fully Automatic Liquid-Based Thin Layer Cytology Preparation Machines, are designed to standardize slide preparation with a high-precision, fully automated system. Capable of handling both gynecological and non-gynecological samples, these machines eliminate cross-contamination and optimize high-volume screening with an unmanned workflow. The DKYJ120 model, in particular, offers a peak throughput of 120 slides per hour, ensuring rapid and reliable results.
The DKYJ600 Full-Automatic Intelligent Dyeing and Sealing Integrated Machine further enhances efficiency with dual robotic arms, automated reagent exchange, and an eco-friendly dewaxing process—a significant breakthrough in medical safety and sustainability. With an impressive speed of 400 slides per hour, this machine is poised to set new standards in pathology lab automation.
Dingco Biotechnology has also developed specialized reagents and consumables, including Cell Preservation Solutions, Papanicolaou Staining Solutions, and Disposable Slide Preparation Chambers. These tailored solutions ensure high-quality slide preparation, consistent staining, and seamless integration with Dingco’s automated systems.
Beyond automation, Dingco is advancing AI-powered diagnostic support by creating a massive standardized database of cytology slides. By integrating cloud-based storage and big data acquisition, Dingco’s technology supports AI model training for next-generation diagnostic precision.
Dingco Biotechnology’s groundbreaking automation solutions are redefining the future of pathology labs, ensuring efficiency, accuracy, and sustainability. As the demand for high-throughput, AI-driven diagnostics grows, Dingco continues to lead the charge in transforming pathology into a fully digital, intelligent discipline.
This presentation which was delivered at the 5th edition of the AI Diagnosis Seminar Series aimed to spark discussions on how AI-driven innovations can revolutionize early disease detection, diagnostic precision, and treatment efficiency, especially through partnerships.
